嵌套适应性临床试验的设计多器官功能障碍综合征儿童在一个单一的研究中
John M VanBuren1, Mark Hall2, Athena F Zuppa3
1Department of Pediatrics, University of Utah, Salt Lake City, UT.
概括
这项研究引入了针对儿科败血症的自适应统计设计,根据免疫状况个性化治疗. 这种创新方法提高了因败血症引起的多器官功能障碍综合征的治疗能力和效率.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 免疫学 免疫学 免疫学
- 生物统计学 生物统计学
背景情况:
- 在儿童中,败血症诱导的多器官功能障碍综合征 (MODS) 带来了复杂的免疫挑战.
- 需要个性化治疗策略来解决儿科败血症中不同的免疫反应.
- 现有的治疗方法可能无法最佳地针对毒症中观察到的多种免疫类型.
研究的目的:
- 描述个性化免疫调节在败血症引起的多器官功能障碍综合征 (PRECISE) 研究的统计设计.
- 概述适应性试验组件,用于评估儿科败血症的免疫调节疗法.
- 详细说明实时免疫检测和队列分配的统计框架.
主要方法:
- 在两个试验中使用了自适应统计设计:GRACE-2 (GM-CSF) 和TRIPS (anakinra).
- 采用频繁的数据监测,以评估无用性和有效性,并预先指定基于模拟的停止边界.
- 在TRIPS试验中,采用了响应适应性随机化,以根据累积的疗效数据优化治疗分配.
主要成果:
- 这两项试验的主要疗效终点是28天内每日儿科物流器官功能障碍-2分数的总和.
- 统计比较包括威尔科克森排列和值测试 (GRACE-2) 和剂量反应曲线 (TRIPS).
- 基于模拟的操作特征展示了在各种场景下适应性设计的行为.
结论:
- PRECISE研究的自适应设计允许基于免疫类型的儿科败血症个性化免疫调节治疗.
- 与传统方法相比,这种创新的统计方法提高了统计能力,并优化了操作特征.
- 该设计可以有效地比较多个活性治疗臂与毒引起的MODS中的安慰剂.
更多相关视频
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.3K
07:01A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
489
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:29Acute Kidney Injury III: Clinical Manifestations
34
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
34
01:29Acute Kidney Injury II: Pathophysiology
33
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
33
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:22Acute Kidney Injury I: Introduction
32
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
32